CLINICAL ROLE -
Atezolizumab, Bevacizumab Combination Lessened Mortality Risk for Kidney Cancer Patients
An immunotherapy combination increased progression-free survival among patients with advanced renal cell carcinoma.
Read More
Trending News Today: ACA Enrollment Will Likely Fall Short of Previous Years
Top news of the day from across the healthcare landscape.
Anti-Hypertensive Drug Linked to Increased Skin Cancer Risk?
A commonly used blood pressure medication may also heighten the risk of developing skin cancer.
Combination Therapy Fails in Late-Stage Clinical Trial of Advanced Gastric Cancer
A combination of ramucirumab plus cisplatin and capecitabine did not improve survival in gastric cancer.
Multiple Sclerosis Drug Delivery Research Targets Extracellular Vesicles
Increasing myelin production by targeting oligodendrocytes shows promise as a treatment for multiple sclerosis.
Combining Prevention Measures Reduces New Cases of HIV
Voluntary male circumcision and starting antiretroviral therapy reduced new cases of HIV by 42% in vulnerable regions.
Trending News Today: Costs for California Public Employees Skyrockets Due to Specialty Drugs
Top news of the day from across the health care landscape.
Medical Cannabis May Improve Neurocognitive Disorder in Patients With HIV
THC found to slow the process of neurodegeneration, which affects nearly half of all patients with HIV.
Are Cryptocurrencies Poised to Revolutionize Pharmacy and Health Care?
Beth Breeden, a professor at Lipscomb University College of Pharmacy, discusses the emergence of bitcoin and Healthcoin.
No Relief from High Drug Costs in Sight
Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015.
What are Some Upcoming Trends in the Specialty Pharmacy Landscape?
Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, highlights emerging trends in the specialty pharmacy landscape.
Tisagenlecleucel Elicits Complete Response in Diffuse Large B-Cell Lymphoma Patients
Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma.
Gene Therapy Provides Hope for Patients with Hemophilia
A majority of patients with hemophilia B avoided joint bleeds after receiving gene therapy.
Long-Acting HIV Injectable Starts Phase 3 Clinical Testing
Long-acting pre-exposure prophylaxis may improve adherence to HIV treatment.
Diabetes, Obesity Cause Hundreds of Thousands of Cancers Annually
Liver cancer is the most common cancer caused by diabetes and obesity.
Trending News Today: Insurance Actuaries Caution Against Individual Mandate Repeal
Trending News Today: FDA Plans to Study Direct-to-Consumer Drug Advertisements
Disease-Modifying Multiple Sclerosis Drugs May Increase Infection Risk
Treating aging patients with immunomodulatory drugs further increases the risk of infections.
Alzheimer's Rates Projected to Double Over Next 20 Years
By 2060, 15 million people in the United States will be living with mild cognitive impairment due to Alzheimer’s disease.
CDC Warns of Increase in Influenza Activity
Several influenza activity indicators were higher than is typically seen for this time of year.
FDA Approves Biologic Drug for Eosinophilic Granulomatosis with Polyangiitis
Officials with the FDA have approved the expanded use of mepolizumab (Nucala) for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA).
Pegfilgrastim Biosimilar Matches Reference Product
A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.
Biologic Drug Receives FDA Approval for Eosinophilic Granulomatosis with Polyangiitis
A high number of patients with eosinophilic granulomatosis treated with mepolizumab achieve remission within 24 weeks compared with placebo patients.
Anti-Hypertensives May Increase the Risk of Skin Cancer
Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma.
New Blood Test May Detect Multiple Sclerosis Worsening
The presence of a nerve protein in the blood may indicate the development of new T1 and T2 lesions resulting from multiple sclerosis.
Research Outlines the Creation of Antibodies Against HIV Infection
These findings could lead to novel a HIV vaccine.
FDA Approves Short-Acting Follow-On Insulin
Ademlog (insulin lispro injection) approved to control blood glucose levels among patients with diabetes.
Trending News Today: Polypharmacy a Significant Concern to Seniors
Trending News Today: Lower Drug Costs May be the Key to Better Medication Adherence
Biologic Migraine Drug Gets FDA Review
Galcanezumab found to significantly decrease the average number of monthly migraine headache days.
